Processing

Please wait...

Settings

Settings

Goto Application

1. MX2017006437 - COMPUESTOS ESPIROISOQUINOLIN-1,4'-PIPERIDINICOS CON ACTIVIDAD MULTIMODAL CONTRA EL DOLOR.

Office Mexico
Application Number 2017006437
Application Date 17.05.2017
Publication Number 2017006437
Publication Date 08.08.2017
Publication Kind A
IPC
C07D 471/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02in which the condensed system contains two hetero rings
10Spiro-condensed systems
CPC
C07D 471/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
02in which the condensed system contains two hetero rings
10Spiro-condensed systems
A61P 25/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
04Centrally acting analgesics, e.g. opioids
C07D 471/20
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
12in which the condensed system contains three hetero rings
20Spiro-condensed systems
Applicants LABORATORIOS DEL DR. ESTEVE, S.A.LABORATORIOS DEL DR. ESTEVE, S.A.
Inventors Carmen ALMANSA-ROSALES
Mónica GARCIA-LOPEZ
Ana María CAAMANO-MOURE
Priority Data 14382465.4 21.11.2014 EP
Title
(ES) COMPUESTOS ESPIROISOQUINOLIN-1,4'-PIPERIDINICOS CON ACTIVIDAD MULTIMODAL CONTRA EL DOLOR.
Abstract
(EN)
The present invention relates to spiro-isoquinoline-1,4'-piperidine compounds having dual pharmacological activity towards both the sigma (σ) receptor and the µ-opiod receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.

Other related publications